A detailed history of Headlands Technologies LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 9,070 shares of KOD stock, worth $37,549. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,070
Holding current value
$37,549
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$2.6 - $10.9 $23,582 - $98,863
9,070 New
9,070 $90,000
Q1 2024

May 07, 2024

BUY
$3.01 - $7.45 $28,706 - $71,050
9,537 New
9,537 $50,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $215M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.